Menu
28/03/2006
Drug trial pair released from hospital
Two of the six men who were hospitalised after a drugs trial went wrong have been allowed to return home.
Doctors at Northwick Park Hospital said that the two men had responded "very well" to treatment and had made an "excellent recovery".
However, four men remain in hospital. One remains in a critical condition, although doctors said he has made gradual improvement over the last week. The three other men are said to be making good progress in their recovery.
The six men fell ill earlier this month after participating in the trial of a new anti-inflammatory drug, TGN 1412. It was the first time that the drug had been tested on humans.
The trial, which was being conducted by US firm Parexel on behalf of German drug manufacturers TeGenero, was immediately suspended when the men fell ill.
The Medical and Healthcare Products Regulatory Agency has launched an investigation.
TeGenero said that the drug had caused glands in two monkeys to swell during earlier tests. The company said that the animals' symptoms had differed from those suffered by the men during the trial.
(KMcA/SP)
Doctors at Northwick Park Hospital said that the two men had responded "very well" to treatment and had made an "excellent recovery".
However, four men remain in hospital. One remains in a critical condition, although doctors said he has made gradual improvement over the last week. The three other men are said to be making good progress in their recovery.
The six men fell ill earlier this month after participating in the trial of a new anti-inflammatory drug, TGN 1412. It was the first time that the drug had been tested on humans.
The trial, which was being conducted by US firm Parexel on behalf of German drug manufacturers TeGenero, was immediately suspended when the men fell ill.
The Medical and Healthcare Products Regulatory Agency has launched an investigation.
TeGenero said that the drug had caused glands in two monkeys to swell during earlier tests. The company said that the animals' symptoms had differed from those suffered by the men during the trial.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
20 March 2006
Company admits trial drug caused side effects in monkeys
The drug which has left six men seriously ill in hospital during a trial caused glands in two monkeys to swell during earlier tests, it has been revealed. However, TeGenero, the German company that manufactured the TGN1412 drug, said that the symptoms shown by the monkeys differed from those suffered by the men during the trial last week.
Company admits trial drug caused side effects in monkeys
The drug which has left six men seriously ill in hospital during a trial caused glands in two monkeys to swell during earlier tests, it has been revealed. However, TeGenero, the German company that manufactured the TGN1412 drug, said that the symptoms shown by the monkeys differed from those suffered by the men during the trial last week.
16 March 2006
Drug trial men remain seriously ill
Two volunteers who fell ill after participating in the trial of a new drug remain in a critical condition. Six men fell ill after participating in the trial of anti-inflammatory drug TGN 1412 at a research unit at the Northwick Park Hospital on Monday. Four of the men are now understood to be improving, although they are still seriously ill.
Drug trial men remain seriously ill
Two volunteers who fell ill after participating in the trial of a new drug remain in a critical condition. Six men fell ill after participating in the trial of anti-inflammatory drug TGN 1412 at a research unit at the Northwick Park Hospital on Monday. Four of the men are now understood to be improving, although they are still seriously ill.
15 March 2006
Six men hospitalised after drug trial
Six men are in intensive care after falling ill during trials of a new anti-inflammatory drug.
Six men hospitalised after drug trial
Six men are in intensive care after falling ill during trials of a new anti-inflammatory drug.
08 December 2006
Transfusion risk for vCJD 'substantial'
People given blood transfusions contaminated with the agent that causes variant Creutzfeldt-Jakob Disease (vCJD) are now considered to be at substantial risk.
Transfusion risk for vCJD 'substantial'
People given blood transfusions contaminated with the agent that causes variant Creutzfeldt-Jakob Disease (vCJD) are now considered to be at substantial risk.
19 April 2006
Drug trial victims offered £5,000
Six volunteers who participated in a drug trial which left them seriously ill have been offered interim payments of £5,000 if they agree not to sue. Lawyers for four of the six men said that the manufacturer of the drug, TeGenero, had agreed to pay the men compensation on the condition that they accepted a “no-fault” procedure.
Drug trial victims offered £5,000
Six volunteers who participated in a drug trial which left them seriously ill have been offered interim payments of £5,000 if they agree not to sue. Lawyers for four of the six men said that the manufacturer of the drug, TeGenero, had agreed to pay the men compensation on the condition that they accepted a “no-fault” procedure.
-
Northern Ireland WeatherToday:It will be cloudy again throughout the day. Mainly dry in the morning, but patchy drizzle in places, becoming more widespread and persistent in the afternoon. Freshening southwesterly winds. Maximum temperature 12 °C.Tonight:Cloudy with a spell of heavy rain pushing south through late evening and the early hours, followed by some clear spells. Minimum temperature 6 °C.
